Informed consent for antipsychotic medication: Do family physicians document obtaining it?

Canadian Family Physician

Volumn 45, Issue JUN., 1999, Pages 1502-1508

  Schachter, Debbie ^a   Kleinman, Irwin ^a   Williams, J Ivan ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; CLINICAL PRACTICE; CROSS-SECTIONAL STUDY; EMPIRICAL APPROACH; FEMALE; GENERAL PRACTICE; HEALTH PERSONNEL ATTITUDE; HUMAN; INFORMED CONSENT; MALE; MENTAL CAPACITY; MENTAL HEALTH THERAPIES; MIDDLE AGED; PROFESSIONAL PATIENT RELATIONSHIP; PSYCHOSIS; STATISTICS;

EMPIRICAL APPROACH; MENTAL HEALTH THERAPIES; PROFESSIONAL PATIENT RELATIONSHIP;

ADULT; ANTIPSYCHOTIC AGENTS; ATTITUDE OF HEALTH PERSONNEL; CROSS-SECTIONAL STUDIES; FAMILY PRACTICE; FEMALE; HUMANS; INFORMED CONSENT; MALE; MENTAL COMPETENCY; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PSYCHOTIC DISORDERS;

EID: 0033144188     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. American Psychiatric Association. Tardive dyskinesia. A task force report of the American Psychiatric Association. Washington, DC: American Psychiatric Association; 1992.
2. Kane JM, Smith JM. Tardive dyskinesia: prevalence and risk factors: 1959 to 1979. Arch Gen Psychiatry 1979;39:473-81.
3. Anderson C, Chakos M, Mailman R, Lieberman J. Emerging roles for novel antipsychotic medications in the treatment of schizophrenia. Psychiatr Clin North Am 1998;21(1):151-219.
4. Kaplan HI, Sadock BI. Kaplan and Sadock's synopsis of psychiatry. Behavioral sciences: clinical psychiatry. 8th ed. Baltimore, Md: Williams and Wilkins; 1998.
5. Corporation Professionelle des Médecins du Québec. Antipsychotics and tardive dyskinesia. Publication officielle de la Corporation professionnelle des medecins du Québec 1984;3:10-1.
6. Reibl v Hughes [1980] 2 S.C.R. 880.
7. Wettstein RM. Legal aspects of neuroleptic-induced movement disorders. In: Wecht CH, editor. Legal medicine. New York, NY: Praeger; 1985. p. 117-79.
8. Munetz MR, Peterson GA. Documenting informed consent for treatment with neuroleptics: an alternative to the consent form. Psychiatr Serv 1996;47(3):302-3.
9. Benjamin S, Munetz MR. CMHC practices related to tardive dyskinesia screening and informed consent for neuroleptic drugs. Hosp Community Psychiatry 1994;45(4):343-6.
10. Lomas J. Teaching old (and not so old) docs new tricks: effective ways to implement research findings. In: Dunn EV, Norton PG, Stewart M, Tudiver F, Bass MJ, editors. Disseminating research/changing practice. London, Engl: Sage Publications; 1994. p. 1-18.
11. Battista RN, Ruiz EA, Endicott AN. From science to practice: the evolving art of communication. In: Dunn EV, Norton PG, Stewart M, Tudiver F, Bass MJ, editors. Disseminating research/changing practice. London, Engl: Sage Publications; 1994. p. 21-31.
12. Hohmann AA, Larson DB, Thompson JW, Beardsley RS. Psychotropic medication prescription in US ambulatory medical care. DICP 1991;25(1):85-9.
13. Gurian BS, Baker EH, Jacobson S, Lagerbom B, Watts P. Informed consent for neuroleptics with elderly patients in two settings. J Am Geriatr Soc 1990;38:37-44.
14. Sovner R, DiMascio A, Berkowitz D, Randolph P. Tardive dyskinesia and informed consent Psychosomatics 1978;19(3):172-7.
15. American Psychiatric Association. Task force Report 18. Tardive dyskinesia. Washington, DC: American Psychiatric Association; 1979.
16. Taylor KM, Kelner M. Informed consent the physician's perspective. Soc Sci Med 1987;24(2):13543.
17. Schachter D, Kleinman I. Survey of physicians' practice: informed consent and tardive dyskinesia. Pilot project. Ottawa, Ont National Health and Research Development Program; 1993. Grant No 6606-4226-57P.
18. Kennedy NJ, Sanborn JS. Disclosure of tardive dyskinesia: effect of written policy on risk disclosure. Psychopharmacol Bull 1992;28(1):93-100.
19. Schachter D, Kleinman I. Psychiatrists' documentation of informed consent Can J Psychiatry 1998;43(10):1012-7.
20. Dunn EV, Bass MJ, Williams JI, Borgiel AE, MacDonald P, Spasoff RA Study of relation of continuing medical education to quality of family physicians' care. J Med Educ 1988;63:775-84.
21. McAuley RG, Paul WM, Morrison GH, Beckett RF, Goldsmith CH. Five-year results of the peer assessment program of the College of Physicians and Surgeons of Ontario. Can Med Assoc J 1990;143:1193-9.
22. Davis DA Thomson M, Oxman AD, Haynes RB. Evidence for the effectiveness of CME: a review of 50 randomized controlled trials. JAMA 1992;268(9):1111-7.
23. Borgiel AE, Williams JI, Bass MJ, Dunn EV, Evensen MK, Lamont CT, et al. Quality of care in family practice: does residency training make a difference? Can Med Assoc J 1989;140:103543.
24. Kleinman I, Schachter D, Jeffries J, Goldhamer P. Informed consent and tardive dyskinesia - long term follow-up. J Nerv Ment Dis 1996;184:517-22.